John Birch
Showing 1–2 of 2 transcripts.
- Milken Institute1h 4m
Digital Health Technology and Solutions
Steven Krein, Katie Agarwal, Matthew Stoudt, Sara Wajnberg, Joel White, Sarah Weinberg, John Birch, George Masregas, Lucia Savage, Hoyt Morgan, Paul Anthony, Lisa Fitzpatrick, Mike Goodman
The event convened leaders from Oscar Insurance, Maven Clinic, Applied VR, and Horizon Government Affairs to analyze how converging macro trends and $10 trillion in capital are reshaping global digital health. Despite rapid venture investment, the panel highlighted critical barriers including fragmented state licensing, stagnant Medicare reimbursement, and misaligned regulatory frameworks that force startups to pivot from consumer to employer models. Looking ahead, the industry aims to drive individualization and equity through unified data standards, risk-based FDA pre-certification, and cross-sector collaboration to eliminate friction in chronic pain management and women's health care.
- Milken Institute59 min
Finding a Cure for the Cost of Durable Therapies
Dan Mendelson, Yvonne Greenstreet, Joe Grogan, Michael Sherman, Mark Skinner, John Birch, Ian Kramer, Jupiter Lazmar
A panel of industry leaders, payers, and advocates highlighted the systemic friction between transformative gene therapies and traditional commercial models that rely on high-volume patient pools to amortize R&D costs. Participants detailed pricing pressures for one-time cures and chronic durable treatments while showcasing innovative risk-sharing agreements, such as Alnylam's outcomes-based pilot with Harvard Pilgrim Health Care, to manage financial exposure. Addressing these challenges, the group called for federal policy reform to eliminate "best price" disincentives and the adoption of flexible valuation frameworks that integrate patient-reported outcomes to prevent insurance affordability crises.